The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
Open accessAbstract
Effective osteoporosis therapy requires agents that increase the amount and/or quality of bone. Any modification of osteoclast-mediated bone resorption by disease or drug treatment, however, elicits a parallel change in osteoblast-mediated bone formation because the processes are tightly coupled. Anabolic approaches now focus on uncoupling osteoblast action from osteoclast formation, for example, by inhibiting sclerostin, an inhibitor of bone formation that does not influence osteoclast differentiation. Here, we report that oncostatin M (OSM) is produced by osteoblasts and osteocytes in mouse bone and that it has distinct effects when acting through 2 different receptors, OSM receptor (OSMR) and leukemia inhibitory factor receptor (LIFR). Specifically, mouse OSM (mOSM) inhibited sclerostin production in a stromal cell line and in primary murine osteoblast cultures by acting through LIFR. In contrast, when acting through OSMR, mOSM stimulated RANKL production and osteoclast formation. A key role for OSMR in bone turnover was confirmed by the osteopetrotic phenotype of mice lacking OSMR. Furthermore, in contrast to the accepted model, in which mOSM acts only through OSMR, mOSM inhibited sclerostin expression in Osmr-/- osteoblasts and enhanced bone formation in vivo. These data reveal what we believe to be a novel pathway by which bone formation can be stimulated independently of bone resorption and provide new insights into OSMR and LIFR signaling that are relevant to other medical conditions, including cardiovascular and neurodegenerative diseases and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Osteocytes, mechanosensing and Wnt signaling
Bonewald, L. F., & Johnson, M. L. (2008) · Bone · doi:10.1016/j.bone.2007.12.224 · Cited by 1,076
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
Dillon, S. R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S. R., Haugen, H. S., Maurer, M., Harder, B., Johnston, J., et al. (2004) · Nature Immunology · doi:10.1038/ni1084 · Cited by 1,015
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L., de Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 892
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784
Osteoclast-derived activity in the coupling of bone formation to resorption
Martin, T. J., & Sims, N. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.004 · Cited by 659
Self-citationBellido, T., Ali, A. A., Gubrij, I., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 641
SOST is a target gene for PTH in bone
Keller, H., & Kneissel, M. (2005) · Bone · doi:10.1016/j.bone.2005.03.018 · Cited by 616
Ware, C. B., Horowitz, M. C., Renshaw, B. R., Hunt, J. S., Liggitt, D., Koblar, S. A., Gliniak, B. C., McKenna, H. J., Papayannopoulou, T., Thoma, B., et al. (1995) · Development · doi:10.1242/dev.121.5.1283 · Cited by 586
Sims, N. A., & Gooi, J. H. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.016 · Cited by 513
Self-citationPalmqvist, P., Persson, E., Conaway, H. H., & Lerner, U. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3353 · Cited by 486
Dual Oncostatin M (OSM) Receptors
Mosley, B., De Imus, C., Friend, D., Boiani, N., Thoma, B., Park, L. S., & Cosman, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32635 · Cited by 386
Kartsogiannis, V, Zhou, H., Horwood, N. J., Thomas, R. J., Hards, D. K., Quinn, J. M. W., Niforas, P., Ng, K. W., Martin, T. J., & Gillespie, M. T. (1999) · Bone · doi:10.1016/s8756-3282(99)00214-8 · Cited by 324
Self-citationModulation of osteoclast differentiation by local factors
Suda, T., Udagawa, N., Nakamura, I., Miyaura, C., & Takahashi, N. (1995) · Bone · doi:10.1016/8756-3282(95)00185-g · Cited by 321
Gronthos, S., Zannettino, A. C. W., Graves, S. E., Ohta, S., Hay, S. J., & Simmons, P. J. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.1.47 · Cited by 282
Gutierrez, S., Javed, A., Tennant, D. K., van Rees, M., Montecino, M., Stein, G. S., Stein, J. L., & Lian, J. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106611200 · Cited by 250
Brown, T. J., Lioubin, M. N., & Marquardt, H. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.2977 · Cited by 219
NEW EMBO MEMBERS' REVIEW: Receptor recognition by gp130 cytokines
Bravo, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2399 · Cited by 211
Romas, E., Udagawa, N., Zhou, H., Tamura, T., Saito, M., Taga, T., Hilton, D. J., Suda, T., Ng, K. W., & Martin, T. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2581 · Cited by 202
Self-citationEphrinB2 Regulation by PTH and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts
Allan, E. H., Häusler, K. D., Wei, T., Gooi, J. H., Quinn, J. M., Crimeen-Irwin, B., Pompolo, S., Sims, N. A., Gillespie, M. T., Onyia, J. E., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080324 · Cited by 199
Self-citationWalker, E. C., McGregor, N. E., Poulton, I. J., Pompolo, S., Allan, E. H., Quinn, J. M., Gillespie, M. T., Martin, T. J., & Sims, N. A. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080706 · Cited by 190
Self-citationDagoneau, N., Scheffer, D., Huber, C., Al-Gazali, L. I., Di Rocco, M., Godard, A., Martinovic, J., Raas-Rothschild, A., Sigaudy, S., Unger, S., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381715 · Cited by 190
Targeted disruption of oncostatin M receptor results in altered hematopoiesis
Tanaka, M., Hirabayashi, Y., Sekiguchi, T., Inoue, T., Katsuki, M., & Miyajima, A. (2003) · Blood · doi:10.1182/blood-2003-02-0367 · Cited by 177
Oncostatin M and Leukemia Inhibitory Factor Do Not Use the Same Functional Receptor in Mice
Ichihara, M., Hara, T., Kim, H. J., Murate, T., & Miyajima, A. (1997) · Blood · doi:10.1182/blood.v90.1.165 · Cited by 152
Linker, R. A., Gold, R., & Lühder, F. (2009) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v29.i1.20 · Cited by 150
Fischer, P., & Hilfiker‐Kleiner, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.1 · Cited by 136
Osteoblasts display receptors for and responses to leukemia‐inhibitory factor
Allan, E. H., Hilton, D. J., Brown, M. A., Evely, R. S., Yumita, S., Metcalf, D., Gough, N. M., Ng, K. W., Nicola, N. A., & Martin, T. J. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041450116 · Cited by 134
Self-citationLin, S., Yamate, T., Taguchi, Y., Borba, V. Z. C., Girasole, G., O’Brien, C. A., Bellido, T., Abe, E., & Manolagas, S. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119729 · Cited by 131
Langdon, C. M., Kerr, C. L., Hassen, M., Hara, T., Arsenault, A. L., & Richards, C. D. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64634-2 · Cited by 113
Hilton, D. J., Nicola, N. A., & Metcalf, D. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041460204 · Cited by 108
Self-citationSong, H. Y., Jeon, E. S., Kim, J.-I., Jung, J. S., & Kim, J. H. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21245 · Cited by 105
Richards, C. D., Langdon, C. M., Deschamps, P. A., Pennica, D., & Shaughnessy, S. G. (2000) · Cytokine · doi:10.1006/cyto.1999.0635 · Cited by 104
Gimble, J. M., Wanker, F., Wang, C., Bass, H. B., Wu, X., Kelly, K. A., Yancopoulos, G. D., & Hill, M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240540113 · Cited by 102
Quinn, J. M. W., Sims, N. A., Saleh, H., Mirosa, D., Thompson, K., Bouralexis, S., Walker, E. C., Martin, T. J., & Gillespie, M. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5720 · Cited by 102
Self-citationEddleston, A., Marenzana, M., Moore, A., Stephens, P. E., Muzylak, M., Marshall, D., & Robinson, M. K. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090403 · Cited by 98
Oncostatin-M: a new bone active cytokine that activates osteoblasts and inhibits bone resorption
Jay, P. R., Lorenzo, J., Bruce, A. G., & Horowitz, M. C. (1996) · Endocrinology · doi:10.1210/endo.137.4.8625883 · Cited by 91
Differentiation potential of a mouse bone marrow stromal cell line
Allan, E. H., Ho, P. W. M., Umezawa, A., Hata, J.-I., Makishima, F., Gillespie, M. T., & Martin, T. J. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10614 · Cited by 79
Self-citationgp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro
Shin, H., Pajevic, P. D., Sims, N. A., Kobayashi, T., Miao, D., Karaplis, A. C., Baron, R., Bringhurst, R., & Kronenberg, H. M. (2003) · Endocrinology · doi:10.1210/en.2003-0839 · Cited by 74
Self-citationSims, N. A., Brennan, K., Spaliviero, J. A., Handelsman, D. J., & Seibel, M. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00311.2005 · Cited by 74
Self-citationCraniosynostosis-Associated Gene Nell-1 Is Regulated by Runx2
Truong, T. V., Zhang, X., Pathmanathan, D., Soo, C. B., & Ting, K. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061012 · Cited by 71
Wang, Q., Wei, X., Zhu, T., Zhang, M., Shen, R., Xing, L., O’Keefe, R. J., & Chen, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610997200 · Cited by 63
Savarese, T. M., Campbell, C. L., McQuain, C., Mitchell, K., Guardiani, R., Quesenberry, P. J., & Nelson, B. E. (2002) · Cytokine · doi:10.1006/cyto.2002.1022 · Cited by 61
de Hooge, A. S. K., van de Loo, F. A. J., Bennink, M. B., de Jong, D. S., Arntz, O. J., Lubberts, E., Richards, C. D., & van den Berg, W. B. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61120-0 · Cited by 61
The generation of highly enriched osteoclast-lineage cell populations
Quinn, J. M. W., Whitty, G. A., Byrne, R. J., Gillespie, M. T., & Hamilton, J. A. (2002) · Bone · doi:10.1016/s8756-3282(01)00654-8 · Cited by 54
Self-citationUnderhill-Day, N., & Heath, J. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1766 · Cited by 52
Sims, N. A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.025 · Cited by 48
Self-citationInhibition of Growth and Induction of Differentiation of Glioma Cell Lines by Oncostatin M (OSM)
Halfter, H., Lotfi, R., Westermann, R., Young, P., Ringelstein, E. B., & Stögbauer, F. (1998) · Growth Factors · doi:10.3109/08977199809117189 · Cited by 44
Affinity Maturation of Leukemia Inhibitory Factor and Conversion to Potent Antagonists of Signaling
Fairlie, W. D., Uboldi, A. D., McCoubrie, J. E., Wang, C. C., Lee, E. F., Yao, S., Souza, D. P. D., Mifsud, S., Metcalf, D., Nicola, N. A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310103200 · Cited by 32
Self-citationDistribution and Binding Properties of Receptors for Leukaemia Inhibitory Factor
Hilton, D. J., Nicola, N. A., & Metcalf, D. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514269.ch14 · Cited by 20
Self-citationGanapathi, M. K., Weizer, A. K., Borsellino, S., Bukowski, R. M., Ganapathi, R. N., Rice, T., Casey, G., & Kawamura, K.-I. (1996) · PubMed · Cited by 18
Shin, C. S., Jeon, M. J., Yang, J., Her, S. J., Kim, D., Kim, S. W., & Kim, S. Y. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01944 · Cited by 16
Cited by
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Mesenchymal stem cell-macrophage crosstalk and bone healing
Pajarinen, J., Lin, T., Gibon, E., Kohno, Y., Maruyama, M., Nathan, K., Lu, L., Yao, Z., & Goodman, S. B. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2017.12.025 · Cited by 999
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Sims, N. A., & Martin, T. J. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2013.215 · Cited by 709
Self-citationOsteoclast differentiation by RANKL and OPG signaling pathways
Udagawa, N., Koide, M., Nakamura, M., Nakamichi, Y., Yamashita, T., Uehara, S., Kobayashi, Y., Furuya, Y., Yasuda, H., Fukuda, C., et al. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01162-6 · Cited by 708
Metadata
- Authors
- Walker, E. C., McGregor, N. E., Poulton, I. J., Solano, M., Pompolo, S., Fernandes, T. J., Constable, M. J., Nicholson, G. C., Zhang, J.-G., Nicola, N. A., Gillespie, M. T., Martin, T. J., & Sims, N. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-02-01
- Volume
- 120
- Issue
- 2
- Pages
- 582-592
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2057035809
- Cited by
- 300
- References
- 52
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.